109 related articles for article (PubMed ID: 11368328)
1. Relative roles of CYP2E1 and CYP1A2 in mouse uroporphyria caused by acetone.
Sinclair PR; Gorman N; Walton HS; Bement WJ; Szakacs J; Gonzalez FJ; Dalton TP; Nebert DW; Sinclair JF
Arch Biochem Biophys; 2000 Dec; 384(2):383-90. PubMed ID: 11368328
[TBL] [Abstract][Full Text] [Related]
2. Uroporphyria in mice: thresholds for hepatic CYP1A2 and iron.
Gorman N; Ross KL; Walton HS; Bement WJ; Szakacs JG; Gerhard GS; Dalton TP; Nebert DW; Eisenstein RS; Sinclair JF; Sinclair PR
Hepatology; 2002 Apr; 35(4):912-21. PubMed ID: 11915039
[TBL] [Abstract][Full Text] [Related]
3. Uroporphyria in Hfe mutant mice given 5-aminolevulinate: a new model of Fe-mediated porphyria cutanea tarda.
Sinclair PR; Gorman N; Walton HS; Bement WJ; Sinclair JF; Gerhard GS; Szakacs JG; Andrews NC; Levy JE
Hepatology; 2001 Feb; 33(2):406-12. PubMed ID: 11172342
[TBL] [Abstract][Full Text] [Related]
4. Absolute requirement for iron in the development of chemically induced uroporphyria in mice treated with 3-methylcholanthrene and 5-aminolevulinate.
Nakano K; Ishizuka M; Sakamoto KQ; Fujita S
Biometals; 2009 Apr; 22(2):345-51. PubMed ID: 18956144
[TBL] [Abstract][Full Text] [Related]
5. CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and iron.
Sinclair PR; Gorman N; Walton HS; Bement WJ; Dalton TP; Sinclair JF; Smith AG; Nebert DW
Toxicol Appl Pharmacol; 2000 Jan; 162(1):60-7. PubMed ID: 10631128
[TBL] [Abstract][Full Text] [Related]
6. Effect of iron and ascorbate on uroporphyria in ascorbate-requiring mice as a model for porphyria cutanea tarda.
Gorman N; Zaharia A; Trask HS; Szakacs JG; Jacobs NJ; Jacobs JM; Balestra D; Sinclair JF; Sinclair PR
Hepatology; 2007 Jan; 45(1):187-94. PubMed ID: 17187429
[TBL] [Abstract][Full Text] [Related]
7. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice.
Zaher H; Buters JT; Ward JM; Bruno MK; Lucas AM; Stern ST; Cohen SD; Gonzalez FJ
Toxicol Appl Pharmacol; 1998 Sep; 152(1):193-9. PubMed ID: 9772215
[TBL] [Abstract][Full Text] [Related]
8. Uroporphyrin accumulation in hepatoma cells expressing human or mouse CYP1A2: relation to the role of CYP1A2 in human porphyria cutanea tarda.
Nichols RC; Cooper S; Trask HW; Gorman N; Dalton TP; Nebert DW; Sinclair JF; Sinclair PR
Biochem Pharmacol; 2003 Feb; 65(4):545-50. PubMed ID: 12566081
[TBL] [Abstract][Full Text] [Related]
9. Ascorbic acid inhibition of cytochrome P450-catalyzed uroporphyrin accumulation.
Sinclair PR; Gorman N; Walton HS; Bement WJ; Jacobs JM; Sinclair JF
Arch Biochem Biophys; 1993 Aug; 304(2):464-70. PubMed ID: 8346921
[TBL] [Abstract][Full Text] [Related]
10. Loss of CYP2E1 and CYP1A2 activity as a function of acetaminophen dose: relation to toxicity.
Snawder JE; Roe AL; Benson RW; Roberts DW
Biochem Biophys Res Commun; 1994 Aug; 203(1):532-9. PubMed ID: 8074700
[TBL] [Abstract][Full Text] [Related]
11. Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-/-) null mutant mice.
Sinclair PR; Gorman N; Dalton T; Walton HS; Bement WJ; Sinclair JF; Smith AG; Nebert DW
Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):149-53. PubMed ID: 9461503
[TBL] [Abstract][Full Text] [Related]
12. Uroporphyria and hepatic carcinogenesis induced by polychlorinated biphenyls-iron interaction: absence in the Cyp1a2(-/-) knockout mouse.
Greaves P; Clothier B; Davies R; Higginson FM; Edwards RE; Dalton TP; Nebert DW; Smith AG
Biochem Biophys Res Commun; 2005 May; 331(1):147-52. PubMed ID: 15845371
[TBL] [Abstract][Full Text] [Related]
13. Ascorbic acid inhibits chemically induced uroporphyria in ascorbate-requiring rats.
Sinclair PR; Gorman N; Sinclair JF; Walton HS; Bement WJ; Lambrecht RW
Hepatology; 1995 Aug; 22(2):565-72. PubMed ID: 7635426
[TBL] [Abstract][Full Text] [Related]
14. Effect of an oral iron chelator or iron-deficient diets on uroporphyria in a murine model of porphyria cutanea tarda.
Gorman N; Zaharia A; Trask HS; Szakacs JG; Jacobs NJ; Jacobs JM; Balestra D; Sinclair JF; Sinclair PR
Hepatology; 2007 Dec; 46(6):1927-834. PubMed ID: 17854053
[TBL] [Abstract][Full Text] [Related]
15. Induction and regulation of CYP2E1 in murine liver after acute and chronic acetone administration.
Forkert PG; Redza ZM; Mangos S; Park SS; Tam SP
Drug Metab Dispos; 1994; 22(2):248-53. PubMed ID: 8013281
[TBL] [Abstract][Full Text] [Related]
16. Role of small differences in CYP1A2 in the development of uroporphyria produced by iron and 5-aminolevulinate in C57BL/6 and SWR strains of mice.
Gorman N; Walton HS; Bement WJ; Honsinger CP; Szakacs JG; Sinclair JF; Sinclair PR
Biochem Pharmacol; 1999 Jul; 58(2):375-82. PubMed ID: 10423181
[TBL] [Abstract][Full Text] [Related]
17. Uroporphyria in the Cyp1a2-/- mouse.
Phillips JD; Kushner JP; Bergonia HA; Franklin MR
Blood Cells Mol Dis; 2011 Dec; 47(4):249-54. PubMed ID: 21880518
[TBL] [Abstract][Full Text] [Related]
18. Cyp1a2 protects against reactive oxygen production in mouse liver microsomes.
Shertzer HG; Clay CD; Genter MB; Schneider SN; Nebert DW; Dalton TP
Free Radic Biol Med; 2004 Mar; 36(5):605-17. PubMed ID: 14980704
[TBL] [Abstract][Full Text] [Related]
19. Role of CYP1A2 and CYP2E1 in the pentoxifylline ciprofloxacin drug interaction.
Peterson TC; Peterson MR; Wornell PA; Blanchard MG; Gonzalez FJ
Biochem Pharmacol; 2004 Jul; 68(2):395-402. PubMed ID: 15194011
[TBL] [Abstract][Full Text] [Related]
20. Protection of the Cyp1a2(-/-) null mouse against uroporphyria and hepatic injury following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Smith AG; Clothier B; Carthew P; Childs NL; Sinclair PR; Nebert DW; Dalton TP
Toxicol Appl Pharmacol; 2001 Jun; 173(2):89-98. PubMed ID: 11384210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
